Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
This guide identifies key asset categories to hold in a new crypto portfolio, with beginner friendly risk considerations.
27,914 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...
El Pollo Loco shares surged after a solid earnings beat and improving store momentum. This article breaks down the re...
The race to commercialize solid-state batteries is accelerating, and QuantumScape sits at the center. This deep dive ...
Nvidia’s new AI architectures debuted at GTC 2026, signaling a longer-term AI infrastructure push. Here’s what that m...
Paysign's 2025 earnings paint a picture of a niche fintech player balancing steady card-services revenue with new par...
The SpaceX IPO could unlock a new era for private-market access. This guide breaks down why SpaceX matters, how to ge...
Investors piled into Nextpower after strong 2026 results and a strategic acquisition. This article breaks down the ca...
As earnings season unfolds, SPIR investors want clarity on the drivers behind spire (spir) 2026 earnings. This guide ...
When a top investor steps up after a steep drop, it signals conviction. This deep dive looks at why First Beijing bou...
Europe’s top AI startups are accelerating moves to the U.S. amid a flood of AI-focused funding. The trend is reshapin...
Sea Limited blends e-commerce, gaming, and fintech in Southeast Asia. This article explores whether its stock is a li...